A Computer Application to Predict Adverse Events in the Short-Term Evolution of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease

Inmaculada Arostegui, María José Legarreta, Irantzu Barrio, Cristobal Esteban, Susana Garcia-Gutierrez, Urko Aguirre, José María Quintana, IRYSS-COPD Group, Jesús Martínez-Tapias, Alba Ruiz, Eduardo Briones, Silvia Vidal, Emilio Perea-Milla, Francisco Rivas, Maximino Redondo, Javier Rodríguez Ruiz, Marisa Baré, Manel Lujan, Concepción Montón, Amalia Moreno, Josune Ormaza, Javier Pomares, Juli Font, Cristina Estirado, Joaquín Gea, Elena Andradas, Juan Antonio Blasco, Nerea Fernández de Larrea, Rosa Girón, María del Puerto Cano Aguirre, Jose Luis Lobo, Esther Pulido, Mikel Sánchez, Luis Alberto Ruiz, Ane Miren Gastaminza, Eva Tabernero, Carmen Haro, Ramon Agüero, Gabriel Gutiérrez, Belén Elizalde, Felipe Aizpuru, Inmaculada Arostegui, Irantzu Barrio, Amaia Bilbao, Cristóbal Esteban, Nerea González, Susana Garcia, Iratxe Lafuente, Urko Aguirre, Miren Orive, Ane Anton, Jose M Quintana, Inmaculada Arostegui, María José Legarreta, Irantzu Barrio, Cristobal Esteban, Susana Garcia-Gutierrez, Urko Aguirre, José María Quintana, IRYSS-COPD Group, Jesús Martínez-Tapias, Alba Ruiz, Eduardo Briones, Silvia Vidal, Emilio Perea-Milla, Francisco Rivas, Maximino Redondo, Javier Rodríguez Ruiz, Marisa Baré, Manel Lujan, Concepción Montón, Amalia Moreno, Josune Ormaza, Javier Pomares, Juli Font, Cristina Estirado, Joaquín Gea, Elena Andradas, Juan Antonio Blasco, Nerea Fernández de Larrea, Rosa Girón, María del Puerto Cano Aguirre, Jose Luis Lobo, Esther Pulido, Mikel Sánchez, Luis Alberto Ruiz, Ane Miren Gastaminza, Eva Tabernero, Carmen Haro, Ramon Agüero, Gabriel Gutiérrez, Belén Elizalde, Felipe Aizpuru, Inmaculada Arostegui, Irantzu Barrio, Amaia Bilbao, Cristóbal Esteban, Nerea González, Susana Garcia, Iratxe Lafuente, Urko Aguirre, Miren Orive, Ane Anton, Jose M Quintana

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a common chronic disease. Exacerbations of COPD (eCOPD) contribute to the worsening of the disease and the patient's evolution. There are some clinical prediction rules that may help to stratify patients with eCOPD by their risk of poor evolution or adverse events. The translation of these clinical prediction rules into computer applications would allow their implementation in clinical practice.

Objective: The goal of this study was to create a computer application to predict various outcomes related to adverse events of short-term evolution in eCOPD patients attending an emergency department (ED) based on valid and reliable clinical prediction rules.

Methods: A computer application, Prediction of Evolution of patients with eCOPD (PrEveCOPD), was created to predict 2 outcomes related to adverse events: (1) mortality during hospital admission or within a week after an ED visit and (2) admission to an intensive care unit (ICU) or an intermediate respiratory care unit (IRCU) during the eCOPD episode. The algorithms included in the computer tool were based on clinical prediction rules previously developed and validated within the Investigación en Resultados y Servicios de Salud COPD study. The app was developed for Windows and Android systems, using Visual Studio 2008 and Eclipse, respectively.

Results: The PrEveCOPD computer application implements the prediction models previously developed and validated for 2 relevant adverse events in the short-term evolution of patients with eCOPD. The application runs under Windows and Android systems and it can be used locally or remotely as a Web application. Full description of the clinical prediction rules as well as the original references is included on the screen. Input of the predictive variables is controlled for out-of-range and missing values. Language can be switched between English and Spanish. The application is available for downloading and installing on a computer, as a mobile app, or to be used remotely via internet.

Conclusions: The PrEveCOPD app shows how clinical prediction rules can be summarized into simple and easy to use tools, which allow for the estimation of the risk of short-term mortality and ICU or IRCU admission for patients with eCOPD. The app can be used on any computer device, including mobile phones or tablets, and it can guide the clinicians to a valid stratification of patients attending the ED with eCOPD.

Trial registration: ClinicalTrials.gov NCT00102401; https://ichgcp.net/clinical-trials-registry/NCT02434536 (Archived by WebCite at http://www.webcitation.org/76iwTxYuA).

International registered report identifier (irrid): RR2-10.1186/1472-6963-11-322.

Keywords: COPD; clinical prediction rule; disease exacerbation; intensive care; mobile app; mortality.

Conflict of interest statement

Conflicts of Interest: None declared.

©Inmaculada Arostegui, María José Legarreta, Irantzu Barrio, Cristobal Esteban, Susana Garcia-Gutierrez, Urko Aguirre, José María Quintana, IRYSS-COPD Group. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 17.04.2019.

Figures

Figure 1
Figure 1
Summary of the process for the 2 outcomes (death and intensive care unit or intermediate respiratory care unit admission): score development and stratification into risk categories. ED: emergency department; ICU: intensive care unit; IRCU: intermediate respiratory care unit; LTHOT: long-term home oxygen therapy; MRC: Medical Research Council; NIMV: noninvasive mechanical ventilation; PCO2: pressure of carbon dioxide.
Figure 2
Figure 2
Screenshot of the application running under the Android platform. Data for an imaginary subject with complete information displayed as an example. ED: emergency department; ICU: intensive care unit; IRCU: intermediate respiratory care unit; LTHOT: long-term home oxygen therapy; MRC: Medical Research Council; NIMV: noninvasive mechanical ventilation; PCO2: pressure of carbon dioxide.
Figure 3
Figure 3
Screenshot of the application running under Windows and Web platforms. Data for an imaginary subject with incomplete information displayed as an example. ED: emergency department; ICU: intensive care unit; IRCU: intermediate respiratory care unit; LTHOT: long-term home oxygen therapy; MRC: Medical Research Council; NIMV: noninvasive mechanical ventilation; PCO2: pressure of carbon dioxide.

References

    1. Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis. 2008 Jul;12(7):703–8.
    1. Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, España PP, Pérez-Izquierdo J, Aguirre U, Aizpiri S, Capelastegui A. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med. 2009 Aug;103(8):1201–8. doi: 10.1016/j.rmed.2009.02.002.
    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) [2019-03-08].
    1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007 Sep 15;176(6):532–55. doi: 10.1164/rccm.200703-456SO.
    1. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010 Sep 16;363(12):1128–38. doi: 10.1056/NEJMoa0909883.
    1. Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009;4:245–51.
    1. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012 Apr;9(2):131–41. doi: 10.3109/15412555.2011.650239.
    1. Roche N, Rabbat A, Zureik M, Huchon G. Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome. Curr Opin Pulm Med. 2010 Mar;16(2):112–7. doi: 10.1097/MCP.0b013e328335f039.
    1. Quintana JM, Esteban C, Unzurrunzaga A, Garcia-Gutierrez S, Gonzalez N, Barrio I, Arostegui I, Lafuente I, Bare M, Fernandez-de-Larrea N, Vidal S, IRYSS-COPD group Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments. BMC Med. 2014 Apr 23;12:66. doi: 10.1186/1741-7015-12-66.
    1. Quintana JM, Esteban C, Unzurrunzaga A, Garcia-Gutierrez S, Gonzalez N, Lafuente I, Bare M, de Larrea NF, Vidal S, IRYSS-COPD Group Prognostic severity scores for patients with COPD exacerbations attending emergency departments. Int J Tuberc Lung Dis. 2014 Dec;18(12):1415–20. doi: 10.5588/ijtld.14.0312.
    1. Steyerberg E. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York: Springer; 2009.
    1. Quintana JM, Esteban C, Barrio I, Garcia-Gutierrez S, Gonzalez N, Arostegui I, Lafuente I, Bare M, Blasco JA, Vidal S, IRYSS-COPD Group The IRYSS-COPD appropriateness study: objectives, methodology, and description of the prospective cohort. BMC Health Serv Res. 2011 Nov 24;11:322. doi: 10.1186/1472-6963-11-322.
    1. Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004 May 30;23(10):1631–60. doi: 10.1002/sim.1742.
    1. Randolph N, Gardner D. Professional Visual Studio 2008. Indianapolis: John Wiley & Sons, Inc; 2008.
    1. Daum B. Professional Eclipse 3 For Java Developers. Indianapolis: John Wiley & Sons, Inc; 2004.
    1. Lee W. C# 2008 Programmer's Reference. Indianapolis: John Wiley & Sons, Inc; 2008.
    1. Legarreta M, Barrio I, Arostegui I, Quintana J, García-Gutierrez S, Esteban C. University of Pais Vasco. [2018-04-13]. PrEveCOPD .
    1. Roche N, Zureik M, Soussan D, Neukirch F, Perrotin D, Urgence BPCO (COPD Emergency) Scientific Committee Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J. 2008 Oct;32(4):953–61. doi: 10.1183/09031936.00129507.
    1. Matkovic Z, Huerta A, Soler N, Domingo R, Gabarrús A, Torres A, Miravitlles M. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration. 2012;84(1):17–26. doi: 10.1159/000335467.
    1. Wynants L, Collins GS, Van Valster B. Key steps and common pitfalls in developing and validating risk models. BJOG. 2017 Feb;124(3):423–432. doi: 10.1111/1471-0528.14170. doi: 10.1111/1471-0528.14170.
    1. The Calculator. 2014. [2018-04-13].
    1. Celli BR, Cote CG, Marin JM, Casanova C, Montes DO, Mendez RA, Pinto PV, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 Mar 04;350(10):1005–12. doi: 10.1056/NEJMoa021322.
    1. Shorr AF, Sun X, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011 Nov;140(5):1177–83. doi: 10.1378/chest.10-3035.
    1. Chang CL, Sullivan GD, Karalus NC, Mills GD, McLachlan JD, Hancox RJ. Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score. Respirology. 2011 Jan;16(1):146–51. doi: 10.1111/j.1440-1843.2010.01866.x.
    1. Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012 Nov;67(11):970–6. doi: 10.1136/thoraxjnl-2012-202103.
    1. Framingham Heart Study. [2018-04-13].
    1. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006 Mar 21;113(11):1424–33. doi: 10.1161/CIRCULATIONAHA.105.584102.
    1. Badawi O, Breslow MJ. Readmissions and death after ICU discharge: development and validation of two predictive models. PLoS One. 2012 Nov;7(11):e48758. doi: 10.1371/journal.pone.0048758.
    1. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008 Feb 12;117(6):743–53. doi: 10.1161/CIRCULATIONAHA.107.699579.
    1. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB, Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009 Feb 28;373(9665):739–45. doi: 10.1016/S0140-6736(09)60443-8.
    1. Moreno-Cid M, Tenías Burillo JM, Rubio-Lorente A, Rodríguez MJ, Bueno-Pacheco G, Román-Ortiz C, Arias Á. Systematic review of the clinical prediction rules for the calculation of the risk of Down syndrome based on ultrasound findings in the second trimester of pregnancy. Prenat Diagn. 2014 Mar;34(3):265–72. doi: 10.1002/pd.4304.
    1. Nicolaides KH. Screening for chromosomal defects. Ultrasound Obstet Gynecol. 2003 Apr;21(4):313–21. doi: 10.1002/uog.128. doi: 10.1002/uog.128.
    1. Schluter PJ, Pritchard G. Mid trimester sonographic findings for the prediction of Down syndrome in a sonographically screened population. Am J Obstet Gynecol. 2005 Jan;192(1):10–6. doi: 10.1016/j.ajog.2004.08.036.
    1. Vergani P, Ghidini A, Weiner S, Locatelli A, Pozzi E, Biffi A. Risk assessment for Down syndrome with genetic sonogram in women at risk. Prenat Diagn. 2008 Dec;28(12):1144–8. doi: 10.1002/pd.2138.
    1. Zhong Y, Longman R, Bradshaw R, Odibo AO. The genetic sonogram: comparing the use of likelihood ratios versus logistic regression coefficients for Down syndrome screening. J Ultrasound Med. 2011 Apr;30(4):463–9.
    1. Bonner C, Fajardo MA, Hui S, Stubbs R, Trevena L. Clinical validity, understandability, and actionability of online cardiovascular disease risk calculators: systematic review. J Med Internet Res. 2018 Feb 01;20(2):e29. doi: 10.2196/jmir.8538.

Source: PubMed

3
订阅